The incidence of flares or new onset of inflammatory bowel diseases in patients with ankylosing spondylitis exposed to anti-TNFA therapy

被引：0
|
作者：
Braun, J.
Baraliakos, X.
Listing, J.
Davis, J.
Van der Heijde, D.
Haibel, H.
Rudwaleit, M.
Sieper, J.
机构：
[1] Ruhr Univ Bochum, Rheumazentrum Ruhrgebeit, D-4690 Herne, Germany
[2] German Rheumatism Res ctr, Berlin, Germany
[3] Univ Calif San Francisco, San Francisco, CA 94143 USA
[4] Univ Hosp, Dept Internal Med, Div Rheumatol, Maastricht, Netherlands
[5] Med Univ Berlin, Berlin, Germany
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2006年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：86 / 86
页数：1
相关论文
共 50 条
  • [1] The incidence of flares or new onset of inflammatory bowel diseases in patients with ankylosing spondylitis exposed to anti-TNFα therapy
    Baraliakos, X.
    Listing, J.
    Sieper, J.
    Braun, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : A43 - A44
  • [2] Differences in the incidence of flares or new onset of inflammatory bowel diseases in patients with ankylosing spondylitis exposed to therapy with anti-tumor necrosis factor α agents
    Braun, J.
    Baraliakos, X.
    Listing, J.
    Davis, J.
    Van der Heijde, D.
    Haibel, H.
    Rudwaleit, M.
    Sieper, J.
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2007, 57 (04): : 639 - 647
  • [3] ARTICULAR MANIFESTATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES TREATED WITH ANTI-TNFA
    Cachen, L.
    Nocturne, G.
    Collins, M.
    Meyer, A.
    Carbonnel, F.
    Mariette, X.
    Seror, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 421 - 421
  • [4] EROSIVE STRUCTURAL CHANGES AND THE IMPACT OF ANTI-TNFA THERAPY IN THE SPINE OF PATIENTS WITH ANKYLOSING SPONDYLITIS
    Baraliakos, X.
    Listing, J.
    Rudwaleit, M.
    Sieper, J.
    Braun, J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (04) : 606 - 607
  • [5] Which Rheumatoid Arthritis, Ankylosing Spondylitis and Juvenile Idiopathic Arthritis Patients Initiate Anti-TNFa Therapy?
    Saraux, Alain
    Benichou, Jacques
    Deslandre, Chantal
    Guillevin, Loic
    Idbrik, Latifa
    Sibilia, Jean
    Soudan, Marc
    Wendling, Daniel
    Guillemin, Francis
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S781 - S781
  • [6] LATENT TUBERCULOSIS SCREENING IN PATIENTS RECEIVING ANTI-TNFA THERAPY FOR INFLAMMATORY BOWEL DISEASE
    Thomas, J.
    Muruganandan, S.
    Van Langenberg, D.
    Thien, F.
    RESPIROLOGY, 2012, 17 : 84 - 84
  • [7] Frequency of anemia of inflammation in patients with ankylosing spondylitis requiring anti-TNFa drugs and therapy-induced changes
    Niccoli, Laura
    Nannini, Carlotta
    Cassara, Emanuele
    Kaloudi, Olga
    Cantini, Fabrizio
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2012, 15 (01) : 56 - 61
  • [8] Effect of anti-TNFa administration on the lipid profile in patients with inflammatory diseases
    Papadakis, J. A.
    Spanakis, E. K.
    Vrentzos, G. E.
    Katsikas, G.
    Karvounaris, S. T.
    Kritikos, H. D.
    Sidiropoulos, P. I.
    Ganotakis, E. S.
    Boumpas, D. T.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 414 - 414
  • [9] Incidence of inflammatory bowel disease in patients with ankylosing spondylitis
    Lai, Shih-Wei
    Kuo, Yu-Hung
    Liao, Kuan-Fu
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (09)
  • [10] THE FREQUENCY OF INFLAMMATORY BOWEL DISEASES IN PATIENTS WITH ANKYLOSING SPONDYLITIS
    Lukina, G.
    Kulakova, P.
    Savenkova, N.
    Volnukhin, E.
    Kovshik, A.
    Alexandrova, E.
    Novikov, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1643 - 1643
12345